A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (what does the body does to the drug) of Rosuvastatin to Measure the Relative Bioavailability (the extent to which a drug or other substance becomes available to the body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet

Trial Identifier: D7550C00002
Sponsor: AstraZeneca
NCTID:: NCT02963116
Start Date: December 2016
Primary Completion Date: March 2017
Study Completion Date: March 2017
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
English Translation

Trial Locations

Country Location
United Kingdom London, United Kingdom, HA1 3UJ